Pain Rehabilitation Virtual Reality (PRVR): Innovations to Enhance Mobility in the Presence of Pain
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 4
- 主要终点
- VR Duration of Use Per Week
研究概览
简要总结
The proposed research is a single arm feasibility trial of pain rehabilitation virtual reality (PRVR) aimed at measuring feasibility, acceptability and utility of VR as well as changes in physical function and fear for adolescents with chronic musculoskeletal pain. The intervention includes standard physiotherapy treatment including functional goal setting and progressive exercise.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 10 Years 至 17 Years(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •10 to 17 years old
- •Musculoskeletal pain (e.g. localized [back, limb], diffuse) not due to acute trauma (e.g. active sprain or fracture)
- •English Language Proficiency
排除标准
- •Significant cognitive impairment (e.g., brain injury)
- •Significant medical or psychiatric problem that would interfere (e.g. psychosis, suicidality)
- •Presents with a condition that interferes with virtual reality usage (e.g., history of seizure, facial injury precluding safe placement of headset, visual impairment, significant hearing impairment impact ability to follow audio instructions).
结局指标
主要结局
VR Duration of Use Per Week
时间窗: Baseline to end of treatment across 6-8 weeks, on average
This outcome is to assess Feasibility, Acceptability, and Utility of VR.
Participant Rated Ease of Use
时间窗: End of treatment at 6-8 weeks, on average
This outcome is to assess Feasibility, Acceptability, and Utility of VR.
Participant Rated Enjoyment
时间窗: End of treatment at 6-8 weeks, on average
This outcome is to assess Feasibility, Acceptability, and Utility of VR.
次要结局
- Pain-related Fear and Avoidance(Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment)
- Physical Function: Lower Extremity(Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment)
- Physical Function: Upper Extremity(Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment)
研究者
Laura E Simons
Professor
Stanford University
